London (Reuters)-The UK will be the first country to launch the low-cost, easy-to-transport AstraZeneca (NASDAQ :) and Oxford University COVID-19 vaccines on Monday. This is another step forward in the global response to pandemics.
Six UK hospitals will give the first of the approximately 530,000 UK-prepared doses. The program will be extended to hundreds of other UK sites in the coming days, and the government hopes to provide tens of millions of doses within the next few months.
“This is a crucial moment in the fight against this terrible virus, and we hope to provide everyone with new hope that the end of this pandemic is visible,” Health Minister Matt Hancock said in a statement. Said in.
Last month the UK became the first country to use another vaccine produced by Pfizer (NYSE :) and BioNTech. Must be stored at very low temperatures. The UK has injected it into about 1 million people so far.
Oxford / AstraZeneca vaccines are inexpensive and can be stored at refrigerator temperature, making them easy to transport and use. India approved a vaccine for emergency use on Sunday.
Cases of COVID-19 in the United Kingdom have increased exponentially in recent weeks, boosted by new, more contagious variants of the virus. Nearly 55,000 new cases occurred on Sunday, and a total of more than 75,000 people died of COVID-19 in the country during the pandemic.
The government was keen to welcome the vaccination program as the most advanced in the world, but it must balance the optimism of its message and plead with the public to stick to the rules to prevent new infections. It didn’t become.
Prime Minister Boris Johnson said on Sunday that stricter restrictions are likely to be introduced, even though millions of citizens are already living under the strictest rules.
The epidemic of the subspecies virus has forced the government to change its approach to vaccination. The UK currently prioritizes the first vaccination of as many people as possible over the second vaccination. Delaying the distribution of second shots should help increase supply.
The change in strategy has been criticized by some British doctors.
Fusion media Alternatively, anyone involved with Fusion Media will not be liable for any loss or damage resulting from relying on the data, quotes, charts, trading signals and other information contained on this website. Please be fully informed about the risks and costs associated with trading in financial markets. This is one of the most risky forms of investment possible.
The “extremely important moment” when the UK embarked on Reuters’ deployment of the AstraZeneca vaccine
https://www.investing.com/news/stock-market-news/pivotal-moment-as-britain-set-to-roll-out-astrazeneca-vaccine-2378828 The “extremely important moment” when the UK embarked on Reuters’ deployment of the AstraZeneca vaccine